SCYL1BP1 inhibitors belong to a specialized class of chemical compounds designed to target and modulate the activity of SCYL1BP1, also known as SCY1-like 1 binding protein 1. SCYL1BP1 is a protein that interacts with and regulates various cellular processes, making it a subject of interest in molecular and cell biology research. While its precise functions are still being elucidated, it has been implicated in intracellular trafficking, protein degradation, and cellular signaling pathways. Inhibitors of SCYL1BP1 are developed to interact with this specific protein, potentially influencing its interactions with binding partners, cellular localization, or its roles in cellular processes where it is involved.
Structurally, SCYL1BP1 inhibitors are meticulously designed to engage specific regions or binding sites on the SCYL1BP1 protein. This interaction can disrupt the normal functioning of SCYL1BP1, potentially affecting its ability to mediate cellular processes it is involved in. The mechanisms by which SCYL1BP1 inhibitors exert their effects can vary, but their primary objective is to provide researchers with a valuable tool for investigating the roles of SCYL1BP1 in various cellular contexts. By studying the biochemical and functional aspects of SCYL1BP1 and its modulation by inhibitors, researchers can gain insights into the complex molecular mechanisms governing fundamental cellular functions and intracellular signaling pathways, contributing to a deeper understanding of cell biology and molecular biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
As a DNA methyltransferase inhibitor, it could modulate SCYL1BP1 gene expression by altering DNA methylation patterns. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Another DNA methyltransferase inhibitor; could influence SCYL1BP1 gene expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
This compound binds GC-rich DNA and inhibits SP1 transcription factor, potentially impacting genes regulated by SP1. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
As a spliceosome inhibitor, it could impact the splicing of SCYL1BP1 mRNA. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
This compound inhibits transcription elongation, potentially reducing SCYL1BP1 expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
This compound inhibits RNA polymerase II, reducing mRNA synthesis, and potentially SCYL1BP1 expression. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
By stabilizing p53, it might influence the expression of genes downstream of the p53 pathway, potentially including SCYL1BP1. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that might stabilize or increase SCYL1BP1 levels, but also influence its transcription indirectly. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
A histone deacetylase inhibitor that can alter gene expression globally. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
This compound intercalates DNA, inhibiting transcription and potentially SCYL1BP1 expression. | ||||||